Abstract 155 Table 1
(G1)
Normal C3 and C4
(G2)
Low levels C3 and C4
(G3)
Low levels C4
(G4)
Variable levels C3 and/or C4
Total
n 149
P (value)
Age at diagnosis/SD)32,1 (13,9)29,5 (10,9)28,5 (15,4)29,5 (13,6)30,6 (13,3)0004
Disease duration
(mean yrs)
10,57,813,078,79,70002
Female (%)98,5%94,1%92,990,995,30001
SLEDAI
(mean/SD)
5,1 (4,5)9.2 (4 ,75)8,07 (4)7,9 (5,4)6,9 (5.0)0001
SLICC (average)1,010,51,30,60.80031
Leukopenia (%)27,929,421,427,327,50.876
Lymphopenia (%)27,932,921,430.328,90769
Hemolytic anemia (%)17,65,928,66,113,40196
Hypergamma (%)30,930,35044.135,60.211
LN (%)36,845,578,635,342.30,0002
Overlap (%) 11,815,214,311,812,80,55
DNAds (%)26,339,45026,542,30011
Sm (%)14,530,314,338,235,40,0001
RNP (%)22,133,37,144,142,40003
Ro (%)35,348,535,75055,90,32
La (%)16,215,214,329,429,20,16
aPL (%)12,530,42526,320,40,1415